Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/248634 
Year of Publication: 
2021
Series/Report no.: 
Research Paper No. 135
Publisher: 
South Centre, Geneva
Abstract: 
While increasing support from WTO members for a proposed waiver from certain obligations under the TRIPS Agreement with regard to health products required for responding to COVID-19 has made a decision on the TRIPS waiver imminent, the waiver will have to be implemented domestically by WTO members through appropriate legislative, administrative or judicial measures, including through executive orders that have been utilized to implement emergency measures in the context of the COVID-19 pandemic. In this regard, the scope of the TRIPS waiver, as well as the terms of applicable free trade agreements (FTAs) and international investment agreements (IIAs) will also impact the policy space available to countries to implement the waiver. Ensuring a broad scope of the waiver, as well as complementary measures to safeguard the implementation of the waiver from potential challenges under FTAs or IIAs will be critical. This research paper discusses some options that could be explored to enable the implementation of the TRIPS waiver by overcoming possible impediments that could arise under such agreements.
Document Type: 
Research Report
Appears in Collections:

Files in This Item:
File
Size
1.52 MB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.